脊髄刺激の世界市場レポート 2024年

脊髄刺激の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.3%の年間複合成長率（CAGR）で43億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、革新的な刺激療法の開発、脊髄刺激の適応症の拡大、低侵襲処置に対する需要の高まり、研究開発への投資の増加、有利な償還政策に起因すると考えられます。予測期間中に予想される主要動向には、脊髄刺激デバイスへの人工知能の統合、感覚異常に基づく刺激の出現、新興経済国における市場での存在感の拡大への注力、充電式刺激装置の採用、患者中心の重視などが含まれます。製品開発におけるアプローチ。

脊髄損傷の有病率の予想される増加は、将来の脊髄刺激市場の成長を促進すると予想されます。脊髄損傷には、脊髄や脊柱管内の神経に対するあらゆる損傷が含まれ、多くの場合、外傷性の出来事や家庭内の事故によって引き起こされます。脊髄損傷の治療には、痛みを軽減するために脊髄に低電圧の電気を供給するプロセスである脊髄刺激が含まれます。 2022年5月の時点で、国立医学図書館は、世界中で毎年 25万人から50万人が脊髄損傷に罹患していると報告しました。米国だけでも、毎年約1万7,000件の新たな脊髄損傷が報告されており、推定28万2,000人のアメリカ人が脊髄損傷の生存者であると考えられています。その結果、脊髄損傷の有病率の増加は、脊髄刺激市場の拡大の触媒として機能しています。

高齢者人口の増加は、脊髄刺激市場の成長に寄与すると予想されます。 65歳以上の高齢者人口は、老化の過程に伴う独特の医療と社会的ニーズを経験しています。高齢者人口の拡大は、加齢に伴う病気や慢性疼痛の蔓延に伴い、脊髄刺激にとって大きな市場機会をもたらしています。 2021年5月、地域生活局（ACL）の報告書は、65歳以上の人口が2009年の3,960万人から2019年には5,410万人へと36％増加することを示しました。予測によると、この人口統計は2060年までに9,470万人に達するとのことです。 2040年までにその数は8,080万人を超えるとの推定もあります。この人口動態の変化は2,000年から2倍以上に増加しており、2019年には総人口の16％から2040年までに21.6％を占めると予想されています。したがって、高齢者人口の拡大が原動力となっています。 脊髄刺激市場の成長を牽引します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の脊髄刺激市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の脊髄刺激市場規模実績と成長、2018～2023年
• 世界の脊髄刺激市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界の脊髄刺激市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 充電式
• 非充電式
• 世界の脊髄刺激市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 腰部手術失敗症候群（FBSS）
• 椎間板変性疾患（DDD）
• 複雑性局所疼痛症候群（CRPS）
• クモ膜炎
• その他
• 世界の脊髄刺激市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 外来手術センター
• 専門クリニック

第7章 地域と国の分析

• 世界の脊髄刺激市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界の脊髄刺激市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 脊髄刺激市場の競合情勢
• 脊髄刺激市場の企業プロファイル
  • NeuroPace Inc.
  • Abbott Laboratories
  • Medtronic PLC
  • Stryker Corporation
  • Boston Scientific Corp.

第31章 その他の大手と革新的な企業

• LivaNova PLC
• Globus Medical Inc.
• ZimVie Inc.
• Avanos Medical Inc.
• Inspire Medical Systems Inc.
• Nevro Corp.
• Axonics Modulation Technologies Inc.
• SPR Therapeutics Inc.
• BlueWind Medical
• Bioness Inc.
• Saluda Medical Pty. Ltd.
• Soterix Medical Inc.
• Synapse Biomedical Inc.
• NeuroMetrix Inc.
• NDI Medical LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Spinal cord stimulation is a relatively recent technique designed to aid in the management of chronic pain when the underlying damage or cause cannot be remedied. This approach involves delivering electrical pulses directly into the spinal cord to regulate and control pain.

The primary types of spinal cord stimulation products are rechargeable and non-rechargeable. Rechargeable devices are those capable of being replenished with electricity. Rechargeable spinal cord stimulation is applied to address persistent neuropathic pain that persists after unsuccessful back surgery. Its applications extend to various conditions, including failed back surgery syndrome (FBSS), degenerative disc disease (DDD), complex regional pain syndrome (CRPS), arachnoiditis, among others. These products find use in different medical settings, including hospitals, ambulatory surgery centers, and specialty clinics.

The spinal cord stimulation market research report is one of a series of new reports from The Business Research Company that provides spinal cord stimulation market statistics, including spinal cord stimulation industry global market size, regional shares, competitors with a spinal cord stimulation market share, detailed spinal cord stimulation market segments, market trends and opportunities, and any further data you may need to thrive in the spinal cord stimulation industry. This spinal cord stimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The spinal cord stimulation market size has grown strongly in recent years. It will grow from $2.85 billion in 2023 to $3.12 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth observed during the historical period can be attributed to factors such as an aging population, the increasing prevalence of chronic pain, rising awareness about spinal cord stimulation, and a growing demand for non-invasive pain management techniques.

The spinal cord stimulation market size is expected to see strong growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to the development of innovative stimulation therapies, the expansion of indications for spinal cord stimulation, a rising demand for minimally invasive procedures, increased investment in research and development, and favorable reimbursement policies. Major trends expected in the forecast period include the integration of artificial intelligence in spinal cord stimulation devices, the emergence of non-paresthesia-based stimulation, a focus on expanding market presence in emerging economies, the adoption of rechargeable stimulators, and an emphasis on patient-centric approaches in product development.

The expected rise in the prevalence of spinal cord injuries is anticipated to drive the growth of the spinal cord stimulation market in the future. Spinal cord injuries encompass any damage to the spinal cord or nerves within the spinal canal, often resulting from traumatic incidents or domestic accidents. The treatment for spinal cord injuries involves spinal cord stimulation, a process that delivers low-voltage electricity to the spinal cord to alleviate pain. As of May 2022, the National Library of Medicine reported that spinal cord injuries affected between 250,000 and 500,000 individuals globally each year. In the United States alone, approximately 17,000 new spinal cord injuries are reported annually, with an estimated 282,000 Americans considered survivors of spinal cord injuries. Consequently, the growing prevalence of spinal cord injuries is serving as a catalyst for the expansion of the spinal cord stimulation market.

The increasing demographic of the elderly population is expected to contribute to the growth of the spinal cord stimulation market. The geriatric population, aged 65 and older, experiences distinctive healthcare and social needs associated with the aging process. The expanding geriatric population represents a significant market opportunity for spinal cord stimulation, as age-related ailments and chronic pain become more prevalent. In May 2021, a report by The Administration for Community Living (ACL) indicated a 36% increase in the population aged 65 and older from 39.6 million in 2009 to 54.1 million in 2019. Projections suggest that this demographic will reach 94.7 million by 2060, with estimates indicating a figure surpassing 80.8 million by 2040. This demographic shift, more than doubling from 2000, is expected to constitute 21.6% of the total population by 2040, compared to 16% in 2019. Hence, the expanding geriatric population is a driving force for the growth of the spinal cord stimulation market.

Technological innovations are a prominent trend gaining traction in the spinal cord stimulation market, with major companies focusing on advanced solutions to maintain their market positions. In December 2022, Abbott Laboratories, a US-based medical device company, introduced the Eterna spinal cord stimulation system, the smallest implantable, rechargeable spinal cord stimulator for chronic pain management currently available. Utilizing Abbott's low-dose BurstDR stimulation, the Eterna SCS has demonstrated a 23% greater relief of pain compared to conventional waveform technology methods, providing a technologically advanced solution for chronic pain treatment.

Major players in the spinal cord stimulation market are concentrating on developing innovative products, such as the Spinal Cord Stimulation System, representing a significant advancement in therapy for spinal cord stimulation. The system involves the implantation of electrodes along the spinal cord to alleviate chronic pain. In March 2023, Nevro, a US-based medical device company specializing in chronic pain treatment, launched the Revolutionary HFX iQ Spinal Cord Stimulation System. Distinguished by its use of artificial intelligence, the system offers personalized pain relief through real-time adjustments based on extensive clinical data. Featuring the HFX algorithm and comprehensive pain management, this system not only represents a significant advancement in spinal cord stimulation therapy but also contributes to the market by offering innovative, data-backed, and AI-powered solutions for individuals with chronic pain.

In November 2023, Nevro, a US-based medical device company for chronic pain, completed the acquisition of VYRSA Technologies for an upfront payment of $40 million and an additional $35 million in milestone payments. This acquisition is notable in the spinal cord stimulation market, diversifying Nevro's product offering, expanding its portfolio and market reach, and addressing unmet medical needs in chronic pain treatment. VYRSA Technologies is a US-based medical technology company with a focus on sacroiliac joint fusion.

Major companies operating in the spinal cord stimulation market report are NeuroPace Inc., Abbott Laboratories, Medtronic PLC, Stryker Corporation, Boston Scientific Corp., LivaNova PLC, Globus Medical Inc., ZimVie Inc., Avanos Medical Inc. , Inspire Medical Systems Inc., Nevro Corp., Axonics Modulation Technologies Inc., SPR Therapeutics Inc., BlueWind Medical, Bioness Inc., Saluda Medical Pty. Ltd., Soterix Medical Inc., Synapse Biomedical Inc., NeuroMetrix Inc., NDI Medical LLC, Neuros Medical Inc., Cirtec Medical Corp., Mainstay Medical International PLC, Gimer Medical, NeuroSigma Inc.

North America was the largest region in the spinal cord stimulation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spinal cord stimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the spinal cord stimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The spinal cord stimulation market consists of sales of neurostimulators, leads, extensions, and handheld controllers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Spinal Cord Stimulation Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on spinal cord stimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for spinal cord stimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spinal cord stimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Rechargeable; Non-rechargeable
• 2) By Application: Failed Back Surgery Syndrome (FBSS); Degenerative Disc Disease (DDD); Complex Regional Pain Syndrome (CRPS); Arachnoiditis; Other Disease Indications
• 3) By End User: Hospitals; Ambulatory Surgery Centers; Specialty Clinics
• Companies Mentioned: NeuroPace Inc.; Abbott Laboratories; Medtronic PLC; Stryker Corporation; Boston Scientific Corp.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Spinal Cord Stimulation Market Characteristics

3. Spinal Cord Stimulation Market Trends And Strategies

4. Spinal Cord Stimulation Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Spinal Cord Stimulation Market Size and Growth

• 5.1. Global Spinal Cord Stimulation Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Spinal Cord Stimulation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Spinal Cord Stimulation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Spinal Cord Stimulation Market Segmentation

• 6.1. Global Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Rechargeable
• Non-rechargeable
• 6.2. Global Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Failed Back Surgery Syndrome (FBSS)
• Degenerative Disc Disease (DDD)
• Complex Regional Pain Syndrome (CRPS)
• Arachnoiditis
• Other Disease Indications
• 6.3. Global Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Ambulatory Surgery Centers
• Specialty Clinics

7. Spinal Cord Stimulation Market Regional And Country Analysis

• 7.1. Global Spinal Cord Stimulation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Spinal Cord Stimulation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Spinal Cord Stimulation Market

• 8.1. Asia-Pacific Spinal Cord Stimulation Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Spinal Cord Stimulation Market

• 9.1. China Spinal Cord Stimulation Market Overview
• 9.2. China Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Spinal Cord Stimulation Market

• 10.1. India Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Spinal Cord Stimulation Market

• 11.1. Japan Spinal Cord Stimulation Market Overview
• 11.2. Japan Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Spinal Cord Stimulation Market

• 12.1. Australia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Spinal Cord Stimulation Market

• 13.1. Indonesia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Spinal Cord Stimulation Market

• 14.1. South Korea Spinal Cord Stimulation Market Overview
• 14.2. South Korea Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Spinal Cord Stimulation Market

• 15.1. Western Europe Spinal Cord Stimulation Market Overview
• 15.2. Western Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Spinal Cord Stimulation Market

• 16.1. UK Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Spinal Cord Stimulation Market

• 17.1. Germany Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Spinal Cord Stimulation Market

• 18.1. France Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Spinal Cord Stimulation Market

• 19.1. Italy Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Spinal Cord Stimulation Market

• 20.1. Spain Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Spinal Cord Stimulation Market

• 21.1. Eastern Europe Spinal Cord Stimulation Market Overview
• 21.2. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Spinal Cord Stimulation Market

• 22.1. Russia Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Spinal Cord Stimulation Market

• 23.1. North America Spinal Cord Stimulation Market Overview
• 23.2. North America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Spinal Cord Stimulation Market

• 24.1. USA Spinal Cord Stimulation Market Overview
• 24.2. USA Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Spinal Cord Stimulation Market

• 25.1. Canada Spinal Cord Stimulation Market Overview
• 25.2. Canada Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Spinal Cord Stimulation Market

• 26.1. South America Spinal Cord Stimulation Market Overview
• 26.2. South America Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Spinal Cord Stimulation Market

• 27.1. Brazil Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Spinal Cord Stimulation Market

• 28.1. Middle East Spinal Cord Stimulation Market Overview
• 28.2. Middle East Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Spinal Cord Stimulation Market

• 29.1. Africa Spinal Cord Stimulation Market Overview
• 29.2. Africa Spinal Cord Stimulation Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Spinal Cord Stimulation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Spinal Cord Stimulation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Spinal Cord Stimulation Market Competitive Landscape And Company Profiles

• 30.1. Spinal Cord Stimulation Market Competitive Landscape
• 30.2. Spinal Cord Stimulation Market Company Profiles
  • 30.2.1. NeuroPace Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic PLC
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Stryker Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Boston Scientific Corp.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Spinal Cord Stimulation Market Other Major And Innovative Companies

• 31.1. LivaNova PLC
• 31.2. Globus Medical Inc.
• 31.3. ZimVie Inc.
• 31.4. Avanos Medical Inc.
• 31.5. Inspire Medical Systems Inc.
• 31.6. Nevro Corp.
• 31.7. Axonics Modulation Technologies Inc.
• 31.8. SPR Therapeutics Inc.
• 31.9. BlueWind Medical
• 31.10. Bioness Inc.
• 31.11. Saluda Medical Pty. Ltd.
• 31.12. Soterix Medical Inc.
• 31.13. Synapse Biomedical Inc.
• 31.14. NeuroMetrix Inc.
• 31.15. NDI Medical LLC

32. Global Spinal Cord Stimulation Market Competitive Benchmarking

33. Global Spinal Cord Stimulation Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Spinal Cord Stimulation Market

35. Spinal Cord Stimulation Market Future Outlook and Potential Analysis

• 35.1 Spinal Cord Stimulation Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Spinal Cord Stimulation Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Spinal Cord Stimulation Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer